Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Mol Cell Biol
2002 Jun 01;2211:3803-19. doi: 10.1128/MCB.22.11.3803-3819.2002.
Show Gene links
Show Anatomy links
Desumoylation activity of Axam, a novel Axin-binding protein, is involved in downregulation of beta-catenin.
Kadoya T
,
Yamamoto H
,
Suzuki T
,
Yukita A
,
Fukui A
,
Michiue T
,
Asahara T
,
Tanaka K
,
Asashima M
,
Kikuchi A
.
???displayArticle.abstract???
Axam has been identified as a novel Axin-binding protein that inhibits the Wnt signaling pathway. We studied the molecular mechanism by which Axam stimulates the downregulation of beta-catenin. The C-terminal region of Axam has an amino acid sequence similar to that of the catalytic region of SENP1, a SUMO-specific protease (desumoylation enzyme). Indeed, Axam exhibited activity to remove SUMO from sumoylated proteins in vitro and in intact cells. The Axin-binding domain is located in the central region of Axam, which is different from the catalytic domain. Neither the Axin-binding domain nor the catalytic domain alone was sufficient for the downregulation of beta-catenin. An Axam fragment which contains both domains was able to decrease the level of beta-catenin. On substitution of Ser for Cys(547) in the catalytic domain, Axam lost its desumoylation activity. Further, this Axam mutant decreased the activity to downregulate beta-catenin. Although Axam strongly inhibited axis formation and expression of siamois, a Wnt-response gene, in Xenopus embryos, Axam(C547S) showed weak activities. These results demonstrate that Axam functions as a desumoylation enzyme to downregulate beta-catenin and suggest that sumoylation is involved in the regulation of the Wnt signaling pathway.
Aberle,
beta-catenin is a target for the ubiquitin-proteasome pathway.
1997, Pubmed
Aberle,
beta-catenin is a target for the ubiquitin-proteasome pathway.
1997,
Pubmed
Behrens,
Functional interaction of beta-catenin with the transcription factor LEF-1.
1996,
Pubmed
,
Xenbase
Bienz,
Linking colorectal cancer to Wnt signaling.
2000,
Pubmed
Bradford,
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
1976,
Pubmed
Buschmann,
SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53.
2000,
Pubmed
Cook,
Wingless inactivates glycogen synthase kinase-3 via an intracellular signalling pathway which involves a protein kinase C.
1996,
Pubmed
Dale,
Signal transduction by the Wnt family of ligands.
1998,
Pubmed
Desterro,
SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation.
1998,
Pubmed
Ding,
Differential regulation of glycogen synthase kinase 3beta by insulin and Wnt signaling.
2000,
Pubmed
Funayama,
Embryonic axis induction by the armadillo repeat domain of beta-catenin: evidence for intracellular signaling.
1995,
Pubmed
,
Xenbase
Gong,
Differential regulation of sentrinized proteins by a novel sentrin-specific protease.
2000,
Pubmed
Gostissa,
Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1.
1999,
Pubmed
Hart,
The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell.
1999,
Pubmed
He,
Glycogen synthase kinase-3 and dorsoventral patterning in Xenopus embryos.
1995,
Pubmed
,
Xenbase
Henderson,
Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover.
2000,
Pubmed
Hino,
Inhibition of the Wnt signaling pathway by Idax, a novel Dvl-binding protein.
2001,
Pubmed
,
Xenbase
Hinoi,
Complex formation of adenomatous polyposis coli gene product and axin facilitates glycogen synthase kinase-3 beta-dependent phosphorylation of beta-catenin and down-regulates beta-catenin.
2000,
Pubmed
Hochstrasser,
Evolution and function of ubiquitin-like protein-conjugation systems.
2000,
Pubmed
Honda,
Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.
1999,
Pubmed
Hurt,
The nuclear pore complex.
1993,
Pubmed
Ikeda,
Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin.
1998,
Pubmed
Johnson,
The ubiquitin-like protein Smt3p is activated for conjugation to other proteins by an Aos1p/Uba2p heterodimer.
1997,
Pubmed
Kadoya,
Inhibition of Wnt signaling pathway by a novel axin-binding protein.
2000,
Pubmed
,
Xenbase
Kahyo,
Involvement of PIAS1 in the sumoylation of tumor suppressor p53.
2001,
Pubmed
Kamitani,
Preferential modification of nuclear proteins by a novel ubiquitin-like molecule.
1997,
Pubmed
Kao,
The entire mesodermal mantle behaves as Spemann's organizer in dorsoanterior enhanced Xenopus laevis embryos.
1988,
Pubmed
,
Xenbase
Kikuchi,
Roles of Axin in the Wnt signalling pathway.
1999,
Pubmed
Kim,
A new SUMO-1-specific protease, SUSP1, that is highly expressed in reproductive organs.
2000,
Pubmed
Kishida,
Axin prevents Wnt-3a-induced accumulation of beta-catenin.
1999,
Pubmed
Kishida,
DIX domains of Dvl and axin are necessary for protein interactions and their ability to regulate beta-catenin stability.
1999,
Pubmed
Kishida,
Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of beta-catenin.
1998,
Pubmed
Kitagawa,
An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin.
1999,
Pubmed
Krieg,
Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs.
1984,
Pubmed
,
Xenbase
Kudo,
Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1.
1998,
Pubmed
Li,
A new protease required for cell-cycle progression in yeast.
1999,
Pubmed
Liu,
Siah-1 mediates a novel beta-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein.
2001,
Pubmed
,
Xenbase
Mahajan,
A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2.
1997,
Pubmed
Matsuzawa,
Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses.
2001,
Pubmed
Matunis,
A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex.
1996,
Pubmed
,
Xenbase
Molenaar,
XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos.
1996,
Pubmed
,
Xenbase
Moon,
From cortical rotation to organizer gene expression: toward a molecular explanation of axis specification in Xenopus.
1998,
Pubmed
,
Xenbase
Mossessova,
Ulp1-SUMO crystal structure and genetic analysis reveal conserved interactions and a regulatory element essential for cell growth in yeast.
2000,
Pubmed
Müller,
SUMO, ubiquitin's mysterious cousin.
2001,
Pubmed
Müller,
Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus.
1998,
Pubmed
Neufeld,
APC-mediated downregulation of beta-catenin activity involves nuclear sequestration and nuclear export.
2000,
Pubmed
Nishida,
A novel mammalian Smt3-specific isopeptidase 1 (SMT3IP1) localized in the nucleolus at interphase.
2000,
Pubmed
Nishida,
Characterization of a novel mammalian SUMO-1/Smt3-specific isopeptidase, a homologue of rat axam, which is an axin-binding protein promoting beta-catenin degradation.
2001,
Pubmed
Okuma,
In vitro SUMO-1 modification requires two enzymatic steps, E1 and E2.
1999,
Pubmed
Polakis,
The oncogenic activation of beta-catenin.
1999,
Pubmed
Rodriguez,
SUMO-1 modification activates the transcriptional response of p53.
1999,
Pubmed
Rosin-Arbesfeld,
The APC tumour suppressor has a nuclear export function.
2000,
Pubmed
Rubinfeld,
Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly.
1996,
Pubmed
Sachdev,
PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies.
2001,
Pubmed
Saitoh,
Ubc9p and the conjugation of SUMO-1 to RanGAP1 and RanBP2.
1998,
Pubmed
,
Xenbase
Sakamoto,
A novel beta-catenin-binding protein inhibits beta-catenin-dependent Tcf activation and axis formation.
2000,
Pubmed
,
Xenbase
Seufert,
Role of a ubiquitin-conjugating enzyme in degradation of S- and M-phase cyclins.
1995,
Pubmed
,
Xenbase
Shibamoto,
Cytoskeletal reorganization by soluble Wnt-3a protein signalling.
1998,
Pubmed
Sokol,
Analysis of Dishevelled signalling pathways during Xenopus development.
1996,
Pubmed
,
Xenbase
Sternsdorf,
Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1.
1997,
Pubmed
,
Xenbase
Tago,
Inhibition of Wnt signaling by ICAT, a novel beta-catenin-interacting protein.
2000,
Pubmed
,
Xenbase
Tian,
Post-transcriptional regulation of Xwnt-8 expression is required for normal myogenesis during vertebrate embryonic development.
1999,
Pubmed
,
Xenbase
Wiechens,
CRM1- and Ran-independent nuclear export of beta-catenin.
2001,
Pubmed
,
Xenbase
Wodarz,
Mechanisms of Wnt signaling in development.
1998,
Pubmed
,
Xenbase
Yamamoto,
Axil, a member of the Axin family, interacts with both glycogen synthase kinase 3beta and beta-catenin and inhibits axis formation of Xenopus embryos.
1998,
Pubmed
,
Xenbase
Yamamoto,
Phosphorylation of axin, a Wnt signal negative regulator, by glycogen synthase kinase-3beta regulates its stability.
1999,
Pubmed
Yeh,
Ubiquitin-like proteins: new wines in new bottles.
2000,
Pubmed
Yoneda,
Nucleocytoplasmic protein traffic and its significance to cell function.
2000,
Pubmed
Yost,
The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3.
1996,
Pubmed
,
Xenbase
Zeng,
The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation.
1997,
Pubmed
,
Xenbase
